Aggregation prone regions and gatekeeping residues in protein sequences

Current Topics in Medicinal Chemistry

Volumn 12, Issue 22, 2012, Pages 2470-2478

  Beerten, Jacinte ^a,b   Schymkowitz, Joost ^a,b   Rousseau, Frederic ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aggregation prone region (APR); Amyloid; Beta structure; Gatekeeper; Protein aggregation

Indexed keywords

AMYLOID; PROTEIN P53; PROTEIN P63; PROTEIN P73; RNA; TAR DNA BINDING PROTEIN;

AGGREGATION PRONE REGION; AMINO ACID SEQUENCE; CELL PROLIFERATION; GATEKEEPING RESIDUE; GENE MUTATION; HUMAN; NERVE DEGENERATION; NONHUMAN; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; DNA-BINDING PROTEINS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MUTATION; PROTEIN FOLDING; PROTEINS;

EID: 84874821954     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611212220003     Document Type: Review

References (145)

1. Astbury, W. T.; Dickinson, S.; Bailey, K., The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem J, 1935, 29 (10), 2351-2601.
2. Jaenicke, R., Folding and association of proteins. Progress in biophysics and molecular biology, 1987, 49 (2-3), 117-237.
3. Zettlmeissl, G.; Rudolph, R.; Jaenicke, R., Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry, 1979, 18 (25), 5567-5571.
4. Zettlmeissl, G.; Rudolph, R.; Jaenicke, R., Reconstitution of lactic dehydrogenase after acid dissociation. The yield of reactivation is determined by conformational rearrangements of the dissociated monomers. European journal of biochemistry / FEBS, 1981, 121 (1), 169-175.
5. Rudolph, R.; Zettlmeissl, G.; Jaenicke, R., Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 2. Reactivation of irreversibly denatured aggregates. Biochemistry, 1979, 18 (25), 5572-5575.
6. Goldberg, M. E.; Rudolph, R.; Jaenicke, R., A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry, 1991, 30 (11), 2790-2797.
7. Neudecker, P.; Robustelli, P.; Cavalli, A.; Walsh, P.; Lundstrom, P.; Zarrine-Afsar, A.; Sharpe, S.; Vendruscolo, M.; Kay, L. E., Structure of an intermediate state in protein folding and aggregation. Science, 2012, 336 (6079), 362-366.
8. Krobath, H.; Estacio, S. G.; Faisca, P. F.; Shakhnovich, E. I., Identification of a Conserved Aggregation-Prone Intermediate State in the Folding Pathways of Spc-SH3 Amyloidogenic Variants. J Mol Biol, 2012.
9. Ren, P. H.; Lauckner, J. E.; Kachirskaia, I.; Heuser, J. E.; Melki, R.; Kopito, R. R., Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol, 2009, 11 (2), 219-225.
10. Rajan, R. S.; Kopito, R. R., Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J Biol Chem, 2005, 280 (2), 1284-1291.
11. Morell, M.; Bravo, R.; Espargaro, A.; Sisquella, X.; Aviles, F. X.; Fernandez-Busquets, X.; Ventura, S., Inclusion bodies: Specificity in their aggregation process and amyloid-like structure. Biochimica Et Biophysica Acta-Molecular Cell Research, 2008, 1783 (10), 1815-1825.
12. Rajan, R. S.; Illing, M. E.; Bence, N. F.; Kopito, R. R., Specificity in intracellular protein aggregation and inclusion body formation. Proc Natl Acad Sci U S A, 2001, 98 (23), 13060-13065.
13. Serpell, L. C.; Sunde, M.; Blake, C. C., The molecular basis of amyloidosis. Cell Mol Life Sci, 1997, 53 (11-12), 871-887.
14. Otzen, D.; Nielsen, P. H., We find them here, we find them there: Functional bacterial amyloid. Cellular and Molecular Life Sciences, 2008, 65 (6), 910-927.
15. Fowler, D. M.; Koulov, A. V.; Alory-Jost, C.; Marks, M. S.; Balch, W. E.; Kelly, J. W., Functional amyloid formation within mam malian tissue. PLoS Biol, 2006, 4 (1), e6.
16. Chiti, F.; Dobson, C. M., Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry, 2006, 75, 333-366.
17. Iconomidou, V. A.; Hamodrakas, S. J., Natural protective amy loids. Curr Protein Pept Sci, 2008, 9 (3), 291-309.
18. Knowles, T. P.; Buehler, M. J., Nanomechanics of functional and pathological amyloid materials. Nature nanotechnology, 2011, 6 (8), 469-479.
19. Maurer-Stroh, S.; Debulpaep, M.; Kuemmerer, N.; de la Paz, M. L.; Martins, I. C.; Reumers, J.; Morris, K. L.; Copland, A.; Serpell, L.; Serrano, L.; Schymkowitz, J. W.; Rousseau, F., Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods, 2010, 7 (3), 237-242.
20. Fernandez-Escamilla, A. M.; Rousseau, F.; Schymkowitz, J.; Serrano, L., Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol, 2004, 22 (10), 1302-3026.
21. Rousseau, F.; Schymkowitz, J.; Serrano, L., Protein aggregation and amyloidosis: confusion of the kinds? Curr Opin Struct Biol, 2006, 16, 1-9.
22. Linding, R.; Schymkowitz, J.; Rousseau, F.; Diella, F.; Serrano, L., A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol, 2004, 342 (1), 345-353.
23. Esteras-Chopo, A.; Serrano, L.; de la Paz, M. L., The amyloid stretch hypothesis: Recruiting proteins toward the dark side. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102 (46), 16672-16677.
24. Teng, P. K.; Eisenberg, D., Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel, 2009, 22 (8), 531-536.
25. Ventura, S.; Zurdo, J.; Narayanan, S.; Parreno, M.; Mangues, R.; Reif, B.; Chiti, F.; Giannoni, E.; Dobson, C. M.; Aviles, F. X.; Serrano, L., Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A, 2004, 101 (19), 7258-7263.
26. Rousseau, F.; Serrano, L.; Schymkowitz, J. W. H., How evolutionary pressure against protein aggregation shaped chaperone specificity. Journal of Molecular Biology, 2006, 355 (5), 1037-1047.
27. Goldschmidt, L.; Teng, P. K.; Riek, R.; Eisenberg, D., Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (8), 3487-3492.
28. Dobson, C. M., Protein folding and misfolding. Nature, 2003, 426 (6968), 884-890.
29. Masino, L.; Nicastro, G.; Calder, L.; Vendruscolo, M.; Pastore, A., Functional interactions as a survival strategy against abnormal aggregation. FASEB J, 2011.
30. Pastore, A.; Temussi, P. A., The two faces of Janus: functional interactions and protein aggregation. Curr Opin Struct Biol, 2012, 22 (1), 30-37.
31. Calamai, M.; Chiti, F.; Dobson, C. M., Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J, 2005, 89 (6), 4201-4210.
32. De Simone, A.; Dhulesia, A.; Soldi, G.; Vendruscolo, M.; Hsu, S. T.; Chiti, F.; Dobson, C. M., Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility. Proc Natl Acad Sci U S A, 2011, 108 (52), 21057-21062.
33. Chiti, F.; Dobson, C. M., Amyloid formation by globular proteins under native conditions. Nat Chem Biol, 2009, 5 (1), 15-22.
34. Luheshi, L. M.; Crowther, D. C.; Dobson, C. M., Protein misfol ding and disease: from the test tube to the organism. Current Opinion in Chemical Biology, 2008, 12 (1), 25-31.
35. Thirumalai, D.; Reddy, G.; Straub, J. E., Role of water in protein aggregation and amyloid polymorphism. Acc Chem Res, 2012, 45 (1), 83-92.
36. Straub, J. E.; Thirumalai, D., Toward a molecular theory of early and late events in monomer to amyloid fibril formation. Annual review of physical chemistry, 2011, 62, 437-463.
37. Sabate, R.; Espargaro, A.; de Groot, N. S.; Valle-Delgado, J. J.; Fernandez-Busquets, X.; Ventura, S., The Role of Protein Sequence and Amino Acid Composition in Amyloid Formation: Scrambling and Backward Reading of IAPP Amyloid Fibrils. J Mol Biol, 2010.
38. Chiti, F.; Stefani, M.; Taddei, N.; Ramponi, G.; Dobson, C. M., Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature, 2003, 424 (6950), 805-808.
39. Chiti, F.; Taddei, N.; Baroni, F.; Capanni, C.; Stefani, M.; Ramponi, G.; Dobson, C. M., Kinetic partitioning of protein folding and aggregation. Nat Struct Biol, 2002, 9 (2), 137-143.
40. Pawar, A. P.; Dubay, K. F.; Zurdo, J.; Chiti, F.; Vendruscolo, M.; Dobson, C. M., Prediction of aggregation-prone and aggre gation-susceptible regions in proteins associated with neuro degenerative diseases. J Mol Biol, 2005, 350 (2), 379-392.
41. Grover, A.; Dugar, D.; Kundu, B., Predicting alternate structure attainment and amyloidogenesis: a nonlinear signal analysis approach. Biochem Biophys Res Commun, 2005, 338 (3), 1410-1416.
42. Sanchez de Groot, N.; Pallares, I.; Aviles, F. X.; Vendrell, J.; Ventura, S., Prediction of hot spots of aggregation in disease-linked polypeptides. BMC Struct Biol, 2005, 5, 18.
43. Tartaglia, G. G.; Cavalli, A.; Pellarin, R.; Caflisch, A., Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci, 2005, 14 (10), 2723-2734.
44. Galzitskaya, O. V.; Garbuzynskiy, S. O.; Lobanov, M. Y., Prediction of amyloidogenic and disordered regions in protein chains. PLoS Comput Biol, 2006, 2 (12), e177.
45. Saiki, M.; Konakahara, T.; Morii, H., Interaction-based evaluation of the propensity for amyloid formation with cross-beta structure. Biochem Biophys Res Commun, 2006, 343 (4), 1262-1271.
46. Thompson, M. J.; Sievers, S. A.; Karanicolas, J.; Ivanova, M. I.; Baker, D.; Eisenberg, D., The 3D profile method for identifying fibril-forming segments of proteins. PNAS, 2006, 103 (11), 4074-4078.
47. Zibaee, S.; Makin, O. S.; Goedert, M.; Serpell, L. C., A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. Protein Sci, 2007, 16 (5), 906-918.
48. Cellmer, T.; Bratko, D.; Prausnitz, J. M.; Blanch, H. W., Protein aggregation in silico. Trends in Biotechnology, 2007, 25 (6), 254-261.
49. Agrawal, N. J.; Kumar, S.; Wang, X. L.; Helk, B.; Singh, S. K.; Trout, B. L., Aggregation in Protein-Based Biotherapeutics: Computational Studies and Tools to Identify Aggregation-Prone Regions. Journal of Pharmaceutical Sciences, 2011, 100 (12), 5081-5095.
50. Caflisch, A., Computational models for the prediction of polypeptide aggregation propensity. Current Opinion in Chemical Biology, 2006, 10 (5), 437-444.
51. Gsponer, J.; Vendruscolo, M., Theoretical approaches to protein aggregation. Protein and Peptide Letters, 2006, 13 (3), 287-293.
52. Roberts, C. J.; Das, T. K.; Sahin, E., Predicting solution aggre gation rates for therapeutic proteins: Approaches and challenges. International Journal of Pharmaceutics, 2011, 418 (2), 318-333.
53. Castillo, V.; Grana-Montes, R.; Sabate, R.; Ventura, S., Prediction of the aggregation propensity of proteins from the primary sequence: Aggregation properties of proteomes. Biotechnology Journal, 2011, 6 (6), 674-685.
54. Makin, O. S.; Atkins, E.; Sikorski, P.; Johansson, J.; Serpell, L. C., Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci U S A, 2005, 102 (2), 315-320.
55. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, R.; Eisenberg, D., Structure of the cross-beta spine of amyloid-like fibrils. Nature, 2005, 435 (7043), 773-778.
56. Sawaya, M. R.; Sambashivan, S.; Nelson, R.; Ivanova, M. I.; Sievers, S. A.; Apostol, M. I.; Thompson, M. J.; Balbirnie, M.; Wiltzius, J. J.; McFarlane, H. T.; Madsen, A. O.; Riekel, C.; Eisenberg, D., Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature, 2007, 447 (7143), 453-457.
57. Sachse, C.; Xu, C.; Wieligmann, K.; Diekmann, S.; Grigorieff, N.; Fandrich, M., Quaternary structure of a mature amyloid fibril from Alzheimer's abeta (1-40) Peptide. J Mol Biol, 2006, 362 (2), 347-354.
58. Jaroniec, C. P.; MacPhee, C. E.; Bajaj, V. S.; McMahon, M. T.; Dobson, C. M.; Griffin, R. G., High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A, 2004, 101 (3), 711-716.
59. Ferguson, N.; Becker, J.; Tidow, H.; Tremmel, S.; Sharpe, T. D.; Krause, G.; Flinders, J.; Petrovich, M.; Berriman, J.; Oschkinat, H.; Fersht, A. R., General structural motifs of amyloid protofilaments. Proc Natl Acad Sci U S A, 2006, 103 (44), 16248-16253.
60. Makin, O. S.; Serpell, L. C., Structures for amyloid fibrils. Febs J, 2005, 272 (23), 5950-5961.
61. Colletier, J. P.; Laganowsky, A.; Landau, M.; Zhao, M. L.; Soriaga, A. B.; Goldschmidt, L.; Flot, D.; Cascio, D.; Sawaya, M. R.; Eisenberg, D., Molecular basis for amyloid-beta polymorphism. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108 (41), 16938-16943.
62. Eisenberg, D.; Jucker, M., The amyloid state of proteins in human diseases. Cell, 2012, 148 (6), 1188-1203.
63. Wang, L.; Maji, S. K.; Sawaya, M. R.; Eisenberg, D.; Riek, R., Bacterial inclusion bodies contain amyloid-like structure. Plos Biology, 2008, 6 (8), 1791-1801.
64. Thompson, M. J.; Sievers, S. A.; Karanicolas, J.; Ivanova, M. I.; Baker, D.; Eisenberg, D., The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A, 2006, 103 (11), 4074-4078.
65. Rousseau, F.; Schymkowitz, J.; Serrano, L., Protein aggregation and amyloidosis: confusion of the kinds? Current Opinion in Structural Biology, 2006, 16 (1), 118-126.
66. Sievers, S. A.; Karanicolas, J.; Chang, H. W.; Zhao, A.; Jiang, L.; Zirafi, O.; Stevens, J. T.; Munch, J.; Baker, D.; Eisenberg, D., Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature, 2011, 475 (7354), 96-100.
67. Landau, M.; Sawaya, M. R.; Faull, K. F.; Laganowsky, A.; Jiang, L.; Sievers, S. A.; Liu, J.; Barrio, J. R.; Eisenberg, D., Towards a pharmacophore for amyloid. PLoS Biol, 2011, 9 (6), e1001080.
68. Halfmann, R.; Alberti, S.; Krishnan, R.; Lyle, N.; O'Donnell, C. W.; King, O. D.; Berger, B.; Pappu, R. V.; Lindquist, S., Opposing Effects of Glutamine and Asparagine Govern Prion Formation by Intrinsically Disordered Proteins. Molecular cell, 2011, 43 (1), 72-84.
69. Toombs, J. A.; McCarty, B. R.; Ross, E. D., Compositional determinants of prion formation in yeast. Mol Cell Biol, 2010, 30 (1), 319-332.
70. Alberti, S.; Halfmann, R.; King, O.; Kapila, A.; Lindquist, S., A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell, 2009, 137 (1), 146-158.
71. Toombs, J. A.; Petri, M.; Paul, K. R.; Kan, G. Y.; Ben-Hur, A.; Ross, E. D., De novo design of synthetic prion domains. Proc Natl Acad Sci U S A, 2012, 109 (17), 6519-6524.
72. De Baets, G.; Reumers, J.; Delgado Blanco, J.; Dopazo, J.; Schymkowitz, J.; Rousseau, F., An Evolutionary Trade-Off between Protein Turnover Rate and Protein Aggregation Favors a Higher Aggregation Propensity in Fast Degrading Proteins. PLoS Comput Biol, 2011, 7 (6), e1002090.
73. Tartaglia, G. G.; Vendruscolo, M., Proteome-level interplay between folding and aggregation propensities of proteins. J Mol Biol, 2008, 402 (5), 919-928.
74. Chiti, F.; Calamai, M.; Taddei, N.; Stefani, M.; Ramponi, G.; Dobson, C. M., Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99, 16419-16426.
75. Yue, P.; Li, Z.; Moult, J., Loss of protein structure stability as a major causative factor in monogenic disease. J Mol Biol, 2005, 353 (2), 459-473.
76. Squier, T. C., Oxidative stress and protein aggregation during biological aging. Experimental Gerontology, 2001, 36 (9), 1539-1550.
77. Powers, E. T.; Balch, W. E., Costly mistakes: translational infidelity and protein homeostasis. Cell, 2008, 134 (2), 204-206.
78. Lee, J. W.; Beebe, K.; Nangle, L. A.; Jang, J.; Longo-Guess, C. M.; Cook, S. A.; Davisson, M. T.; Sundberg, J. P.; Schimmel, P.; Ackerman, S. L., Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature, 2006, 443 (7107), 50-55.
79. Fersht, A. R.; Matouschek, A.; Serrano, L., The folding of an enzyme. I. Theory of protein engineering analysis of stability and pathway of protein folding. J Mol Biol, 1992, 224 (3), 771-782.
80. Ganesan, A.; Watkinson, A.; Moore, B. D., Biophysical charac terisation of thermal-induced precipitates of recombinant anthrax protective antigen: Evidence for kinetically trapped unfolding domains in solid-state. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.5, 2012.
81. Zhang, A.; Jordan, J. L.; Ivanova, M. I.; Weiss, W. F.; Roberts, C. J.; Fernandez, E. J., Molecular Level Insights into Thermally Induced alpha-Chymotrypsinogen A Amyloid Aggregation Mecha nism and Semiflexible Protofibril Morphology. Biochemistry, 2010, 49 (49), 10553-10564.
82. Cromwell, M. E.; Hilario, E.; Jacobson, F., Protein aggregation and bioprocessing. The AAPS journal, 2006, 8 (3), E572-E579.
83. Powers, E. T.; Morimoto, R. I.; Dillin, A.; Kelly, J. W.; Balch, W. E., Biological and chemical approaches to diseases of proteostasis deficiency. Annual review of biochemistry, 2009, 78, 959-991.
84. Balch, W. E.; Morimoto, R. I.; Dillin, A.; Kelly, J. W., Adapting proteostasis for disease intervention. Science, 2008, 319 (5865), 916-919.
85. Hartl, F. U.; Bracher, A.; Hayer-Hartl, M., Molecular chaperones in protein folding and proteostasis. Nature, 2011, 475 (7356), 324-332.
86. Xu, J.; Reumers, J.; Couceiro, J. R.; De Smet, F.; Gallardo, R.; Rudyak, S.; Cornelis, A.; Rozenski, J.; Zwolinska, A.; Marine, J. C.; Lambrechts, D.; Suh, Y. A.; Rousseau, F.; Schymkowitz, J., Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nature Chemical Biology, 2011, 7 (5), 285-295.
87. Olzscha, H.; Schermann, S. M.; Woerner, A. C.; Pinkert, S.; Hecht, M. H.; Tartaglia, G. G.; Vendruscolo, M.; Hayer-Hartl, M.; Hartl, F. U.; Vabulas, R. M., Amyloid-like aggregates sequester nume rous metastable proteins with essential cellular functions. Cell, 2011, 144 (1), 67-78.
88. Bucciantini, M.; Cecchi, C., Biological membranes as protein aggregation matrices and targets of amyloid toxicity. Methods Mol Biol, 2011, 648, 231-243.
89. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C. M.; Stefani, M., Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 2002, 416 (6880), 507-511.
90. Ganusova, E. E.; Ozolins, L. N.; Bhagat, S.; Newnam, G. P.; Wegrzyn, R. D.; Sherman, M. Y.; Chernoff, Y. O., Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast. Mol Cell Biol, 2006, 26 (2), 617-629.
91. Mukrasch, M. D.; von Bergen, M.; Biernat, J.; Fischer, D.; Griesinger, C.; Mandelkow, E.; Zweckstetter, M., The jaws of the tau-microtubule interaction. J Biol Chem, 2007, 282 (16), 12230-12239.
92. Shankar, G. M.; Li, S.; Mehta, T. H.; Garcia-Munoz, A.; Shepardson, N. E.; Smith, I.; Brett, F. M.; Farrell, M. A.; Rowan, M. J.; Lemere, C. A.; Regan, C. M.; Walsh, D. M.; Sabatini, B. L.; Selkoe, D. J., Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med, 2008, 14 (8), 837-842.
93. Townsend, M.; Shankar, G. M.; Mehta, T.; Walsh, D. M.; Selkoe, D. J., Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol, 2006, 572 (Pt 2), 477-492.
94. Lesne, S.; Koh, M. T.; Kotilinek, L.; Kayed, R.; Glabe, C. G.; Yang, A.; Gallagher, M.; Ashe, K. H., A specific amyloid-beta protein assembly in the brain impairs memory. Nature, 2006, 440 (7082), 352-357.
95. Gong, Y.; Chang, L.; Viola, K. L.; Lacor, P. N.; Lambert, M. P.; Finch, C. E.; Krafft, G. A.; Klein, W. L., Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A, 2003, 100 (18), 10417-10422.
96. Kayed, R.; Pensalfini, A.; Margol, L.; Sokolov, Y.; Sarsoza, F.; Head, E.; Hall, J.; Glabe, C., Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem, 2008.
97. Laganowsky, A.; Liu, C.; Sawaya, M. R.; Whitelegge, J. P.; Park, J.; Zhao, M.; Pensalfini, A.; Soriaga, A. B.; Landau, M.; Teng, P. K.; Cascio, D.; Glabe, C.; Eisenberg, D., Atomic view of a toxic amyloid small oligomer. Science, 2012, 335 (6073), 1228-1231.
98. Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. G., Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 2003, 300 (5618), 486-489.
99. Sambashivan, S.; Liu, Y.; Sawaya, M. R.; Gingery, M.; Eisenberg, D., Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature, 2005, 437 (7056), 266-269.
100. Bousset, L.; Briki, F.; Doucet, J.; Melki, R., The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. J Struct Biol, 2003, 141 (2), 132-142.
101. Bousset, L.; Thomson, N. H.; Radford, S. E.; Melki, R., The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro. Embo J, 2002, 21 (12), 2903-2911.
102. Pikkarainen, M.; Hartikainen, P.; Alafuzoff, I., Ubiquitinated p62-positive, TDP-43-negative inclusions in cerebellum in fronto temporal lobar degeneration with TAR DNA binding protein 43. Neuropathology: official journal of the Japanese Society of Neuropathology, 2010, 30 (2), 197-199.
103. Neumann, M.; Sampathu, D. M.; Kwong, L. K.; Truax, A. C.; Micsenyi, M. C.; Chou, T. T.; Bruce, J.; Schuck, T.; Grossman, M.; Clark, C. M.; McCluskey, L. F.; Miller, B. L.; Masliah, E.; Mackenzie, I. R.; Feldman, H.; Feiden, W.; Kretzschmar, H. A.; Trojanowski, J. Q.; Lee, V. M., Ubiquitinated TDP-43 in fronto temporal lobar degeneration and amyotrophic lateral sclerosis. Science, 2006, 314 (5796), 130-133.
104. Arai, T.; Hasegawa, M.; Akiyama, H.; Ikeda, K.; Nonaka, T.; Mori, H.; Mann, D.; Tsuchiya, K.; Yoshida, M.; Hashizume, Y.; Oda, T., TDP-43 is a component of ubiquitin-positive tau-negative inclu sions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun, 2006, 351 (3), 602-211.
105. Yang, C.; Tan, W.; Whittle, C.; Qiu, L.; Cao, L.; Akbarian, S.; Xu, Z., The C-Terminal TDP-43 Fragments Have a High Aggregation Propensity and Harm Neurons by a Dominant-Negative Mecha nism. PLoS One, 2010, 5 (12), e15878.
106. Johnson, B. S.; McCaffery, J. M.; Lindquist, S.; Gitler, A. D., A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A, 2008, 105 (17), 6439-6444.
107. Da Cruz, S.; Cleveland, D. W., Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Current opinion in neuro biology, 2011, 21 (6), 904-919.
108. Li, Y.; Prives, C., Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene, 2007, 26 (15), 2220-2225.
109. Melino, G., p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell death and differentiation, 2011, 18 (9), 1487-1499.
110. Xu, J.; Reumers, J.; Couceiro, J. R.; De Smet, F.; Gallardo, R.; Rudyak, S.; Cornelis, A.; Rozenski, J.; Zwolinska, A.; Marine, J. C.; Lambrechts, D.; Suh, Y. A.; Rousseau, F.; Schymkowitz, J., Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol, 2011, 7 (5), 285-295.
111. Beerten, J.; Jonckheere, W.; Rudyak, S.; Xu, J.; Wilkinson, H.; De Smet, F.; Schymkowitz, J.; Rousseau, F., Aggregation gatekeepers modulate protein homeostasis of aggregating sequences and affect bacterial fitness. Protein Eng Des Sel, 2012.
112. Eisenberg, D.; Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Sambashivan, S.; Ivanova, M. I.; Madsen, A. O.; Riekel, C., The structural biology of protein aggregation diseases: Fundamental questions and some answers. Acc Chem Res, 2006, 39 (9), 568-575.
113. Bratko, D.; Cellmer, T.; Prausnitz, J. M.; Blanch, H. W., Molecular simulation of protein aggregation. Biotechnology and Bioengi neering, 2007, 96 (1), 1-8.
114. Fitzpatrick, A. W.; Knowles, T. P.; Waudby, C. A.; Vendruscolo, M.; Dobson, C. M., Inversion of the balance between hydrophobic and hydrogen bonding interactions in protein folding and aggregation. PLoS Comput Biol, 2011, 7 (10), e1002169.
115. Rousseau, F.; Serrano, L.; Schymkowitz, J. W., How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol, 2006, 355 (5), 1037-1047.
116. Monsellier, E.; Chiti, F., Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO reports, 2007, 8 (8), 737-742.
117. Monsellier, E.; Ramazzotti, M.; de Laureto, P. P.; Tartaglia, G. G.; Taddei, N.; Fontana, A.; Vendruscolo, M.; Chiti, F., The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. Biophysical Journal, 2007, 93 (12), 4382-4391.
118. de Groot, N. S.; Ventura, S., Protein aggregation profile of the bacterial cytosol. PLoS One, 2010, 5 (2), e9383.
119. Reumers, J.; Maurer-Stroh, S.; Schymkowitz, J.; Rousseau, F., Protein Sequences Encode Safeguards Against Aggregation. Human Mutation, 2009, 30 (3), 431-437.
120. Buell, A. K.; Tartaglia, G. G.; Birkett, N. R.; Waudby, C. A.; Vendruscolo, M.; Salvatella, X.; Welland, M. E.; Dobson, C. M.; Knowles, T. P. J., Position-Dependent Electrostatic Protection against Protein Aggregation. Chembiochem, 2009, 10 (8), 1309-1312.
121. Silow, M.; Oliveberg, M., Transient aggregates in protein folding are easily mistaken for folding intermediates. Proc Natl Acad Sci U S A, 1997, 94 (12), 6084-6086.
122. Otzen, D. E.; Kristensen, O.; Oliveberg, M., Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. Proc Natl Acad Sci U S A, 2000, 97 (18), 9907-9912.
123. Matysiak, S.; Clementi, C., Minimalist protein model as a diagnostic tool for misfolding and aggregation. Journal of Molecular Biology, 2006, 363 (1), 297-308.
124. Abeln, S.; Frenkel, D., Disordered flanks prevent peptide aggre gation. PLoS Comput Biol, 2008, 4 (12), e1000241.
125. Parrini, C.; Taddei, N.; Ramazzotti, M.; Degl'Innocenti, D.; Ramponi, G.; Dobson, C. M.; Chiti, F., Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. Structure (Camb), 2005, 13 (8), 1143-1151.
126. Gerling, U. I.; Brandenburg, E.; von Berlepsch, H.; Pagel, K.; Koksch, B., Structure analysis of an amyloid-forming model peptide by a systematic glycine and proline scan. Biomacro molecules, 2011, 12 (8), 2988-2996.
127. Tartaglia, G. G.; Caflisch, A., Computational analysis of the S. cerevisiae proteome reveals the function and cellular localization of the least and most amyloidogenic proteins. Proteins, 2007, 68 (1), 273-278.
128. Chen, Y. W.; Dokholyan, N. V., Natural selection against protein aggregation on self-interacting and essential proteins in yeast, fly, and worm. Molecular Biology and Evolution, 2008, 25 (8), 1530-1533.
129. Wang, X.; Zhou, Y.; Ren, J. J.; Hammer, N. D.; Chapman, M. R., Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci U S A, 2010, 107 (1), 163-168.
130. Sarkar, A.; Kumar, S.; Grover, A.; Sundar, D., Protein Aggregation in Neurodegenerative Diseases: Insights from Computational Analyses. Current Bioinformatics, 2012, 7 (1), 87-95.
131. Kurnik, M.; Hedberg, L.; Danielsson, J.; Oliveberg, M., Folding without charges. Proceedings of the National Academy of Sciences, 2012, 109 (15), 5705-5710.
132. Van Durme, J.; Maurer-Stroh, S.; Gallardo, R.; Wilkinson, H.; Rousseau, F.; Schymkowitz, J., Accurate Prediction of DnaK-Peptide Binding via Homology Modelling and Experimental Data. Plos Computational Biology, 2009, 5 (8).
133. Tartaglia, G. G.; Pechmann, S.; Dobson, C. M.; Vendruscolo, M., Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends in Biochemical Sciences, 2007, 32 (5), 204-206.
134. Castillo, V.; Grana-Montes, R.; Ventura, S., The aggregation properties of Escherichia coli proteins associated with their cellular abundance. Biotechnol J, 2011, 6 (6), 752-760.
135. Thangakani, A. M.; Kumar, S.; Velmurugan, D.; Gromiha, M. S. M., How do thermophilic proteins resist aggregation? Proteins-Structure Function and Bioinformatics, 2012, 80 (4), 1003-1015.
136. Kumar, S.; Singh, S. K.; Wang, X. L.; Rup, B.; Gill, D., Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions. Pharmaceutical Research, 2011, 28 (5), 949-961.
137. Castillo, V.; Ventura, S., Amyloidogenic Regions and Interaction Surfaces Overlap in Globular Proteins Related to Conformational Diseases. Plos Computational Biology, 2009, 5 (8).
138. Masino, L.; Nicastro, G.; Calder, L.; Vendruscolo, M.; Pastore, A., Functional interactions as a survival strategy against abnormal aggregation. Faseb Journal, 2011, 25 (1), 45-54.
139. Lopez de la Paz, M.; Serrano, L., Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A, 2004, 101 (1), 87-92.
140. Tartaglia, G. G.; Cavalli, A.; Pellarin, R.; Caflisch, A., Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Science, 2005, 14 (10), 2723-2734.
141. Conchillo-Sole, O.; de Groot, N. S.; Aviles, F. X.; Vendrell, J.; Daura, X.; Ventura, S., AGGRESCAN: a server for the prediction and evaluation of hot spots of aggregation in polypeptides. Bmc Bioinformatics, 2007, 8.
142. Trovato, A.; Seno, F.; Tosatto, S. C. E., The PASTA server for protein aggregation prediction. Protein Engineering Design & Selection, 2007, 20 (10), 521-523.
143. Bryan, A. W.; Menke, M.; Cowen, L. J.; Lindquist, S. L.; Berger, B., BETASCAN: Probable beta-amyloids Identified by Pairwise Probabilistic Analysis. Plos Computational Biology, 2009, 5 (3).
144. Frousios, K. K.; Iconomidou, V. A.; Karletidi, C. M.; Hamodrakas, S. J., Amyloidogenic determinants are usually not buried. Bmc Structural Biology, 2009, 9.
145. Garbuzynskiy, S. O.; Lobanov, M. Y.; Galzitskaya, O. V., FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics, 2010, 26 (3), 326-332.